What is the most likely diagnosis in a child presenting with urticarial skin lesions, fever, abdominal pain, facial edema, and leukocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: IgA Vasculitis (Henoch-Schönlein Purpura)

The constellation of urticarial skin lesions, fever, abdominal pain, facial edema (puffy face), and leukocytosis in a child is most consistent with IgA vasculitis (formerly Henoch-Schönlein purpura), which is the most common vasculitis in children. 1, 2

Key Diagnostic Features Supporting IgA Vasculitis

Clinical Presentation

  • Palpable purpura or urticarial lesions are the hallmark cutaneous manifestation, typically appearing on the lower extremities and buttocks but can be widespread 1, 2
  • Colicky abdominal pain is a frequent gastrointestinal manifestation and can be severe enough to mimic an acute surgical abdomen 1, 3
  • Fever commonly accompanies the acute presentation 1
  • Facial edema can occur as part of the systemic inflammatory response 2
  • Leukocytosis is a characteristic laboratory finding during the acute phase 2

Critical Diagnostic Steps

Immediate evaluation should include:

  • Skin biopsy of a fresh lesion (ideally <24 hours old) to confirm leukocytoclastic vasculitis with IgA deposition on direct immunofluorescence 4, 2, 5
  • Urinalysis to detect proteinuria and/or hematuria, which occurs in up to 50% of cases and indicates renal involvement 2
  • Complete blood count documenting the leukocytosis and checking for thrombocytopenia 2
  • Inflammatory markers (ESR or CRP), which are typically elevated 4, 2
  • Stool examination if gastrointestinal symptoms are prominent, as concomitant infections can complicate the presentation 1

Important Differential Diagnoses to Exclude

Urticarial Vasculitis

While urticarial vasculitis can present with similar skin findings, wheals in urticarial vasculitis persist for days (not hours) and resolve with residual bruising or hyperpigmentation 4, 6, 5. The presence of fever, abdominal pain, and systemic symptoms makes IgA vasculitis more likely than isolated urticarial vasculitis 5.

Incomplete Kawasaki Disease

This is a critical consideration that must not be missed because delayed treatment increases the risk of coronary artery aneurysms from 15-25% 7. Kawasaki disease should be strongly considered when:

  • Fever persists ≥5 days with 2-3 principal clinical features 7
  • The urticarial rash qualifies as the polymorphous exanthema criterion 7
  • Facial swelling (puffy face) represents oral-cavity changes 7
  • Abdominal pain is a recognized gastrointestinal manifestation 7
  • Leukocytosis ≥12,000/mm³ is characteristic 7

Urgent echocardiography is mandatory to evaluate for coronary artery abnormalities, decreased left-ventricular contractility, mitral regurgitation, or pericardial effusion 7. If Kawasaki disease cannot be excluded, intravenous immunoglobulin (IVIG) must be administered within 10 days of fever onset to prevent irreversible cardiac damage 7.

Acute Hemorrhagic Edema of Infancy

In children under 2 years, acute hemorrhagic edema presents with low-grade fever, facial edema, and purpuric lesions but is benign with spontaneous recovery in 1-3 weeks without visceral involvement 8. The presence of significant abdominal pain and leukocytosis makes IgA vasculitis more likely 8.

Rocky Mountain Spotted Fever

Although RMSF can present with fever, rash, abdominal pain, and periorbital edema in children, the rash is typically maculopapular (not urticarial) appearing 2-4 days after fever onset and may become petechial 4. Thrombocytopenia is more characteristic than leukocytosis 4.

Management Algorithm

Once IgA vasculitis is confirmed:

  1. Assess disease severity:

    • Monitor for gastrointestinal complications (hematemesis, hematochezia, intussusception) 1
    • Serial urinalysis to detect progressive renal involvement 2
    • Document extent of skin involvement and systemic symptoms 1
  2. Initiate treatment based on severity:

    • Supportive care with hydration and analgesia for mild cases 1, 3
    • High-dose corticosteroids (typically 1-2 mg/kg/day prednisone) for severe abdominal pain, gastrointestinal bleeding, or significant renal involvement 1
    • Proton pump inhibitors if gastrointestinal symptoms are prominent 1
  3. Monitor for complications:

    • Serial urinalysis weekly for the first month, then monthly for 6 months to detect delayed nephritis 2
    • Repeat stool examination if diarrhea or bloody stools develop, as concomitant infections occur in up to 42.9% of cases 1

Common Pitfalls to Avoid

  • Do not dismiss the urticarial rash as a simple allergic reaction and treat with antihistamines alone; this delays diagnosis of a potentially serious systemic vasculitis 7
  • Do not assume ordinary urticaria when fever and systemic symptoms are present; ordinary urticaria does not cause fever 9
  • Do not overlook incomplete Kawasaki disease, especially in infants and young children with fewer than 5 principal features, as they remain at substantial risk for coronary complications 7
  • Do not delay skin biopsy when wheals persist >24 hours or when systemic features suggest vasculitis 4, 6
  • Do not fail to screen for renal involvement even when urinalysis is initially normal, as nephritis can develop weeks after the initial presentation 2

References

Research

IgA vasculitis presenting as abdominal pain and rash.

Proceedings (Baylor University. Medical Center), 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Evaluation in Allergic Urticaria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Kawasaki Disease (Cited Evidence)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Acute hemorrhagic edema of infancy.

Archives of Iranian medicine, 2008

Guideline

Acute Urticaria Presentation and Exceptions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the differential diagnosis and treatment approach for a patient presenting with a vasculitic pruritic rash, considering potential underlying autoimmune disorders, infections, and allergic reactions?
What are the differential diagnoses for a female patient presenting with excoriated papules and erythematous urticarial plaques, with a history of urticarial plaques lasting more than 24 hours, and pathological findings of mild superficial perivascular lymphocytic infiltration and mild papillary edema, beyond non-bullous bullous pemphigoid (BP) and urticarial vasculitis (UV)?
What is the recommended evaluation and management for a child with Henoch‑Schönlein purpura (IgA vasculitis) presenting with palpable purpura, arthralgia, abdominal pain, and possible renal involvement?
How can IgA (Immunoglobulin A) vasculitis cause upper gastrointestinal bleeding (UGIB)?
What are the key differences between leukocytoclastic vasculitis and urticarial vasculitis regarding clinical presentation, histology, lesion duration, and treatment?
How should I explain to a patient the MRI findings of mild common flexor tendinosis with low‑grade partial‑thickness tearing at the origin, mild common extensor tendinosis, and an intermediate‑grade partial‑thickness tear of the triceps insertion measuring 8 mm on a background of moderate tendinosis?
What is the appropriate starting dose and titration schedule for Nexito Forte (clonazepam and escitalopram) in an adult without hepatic or renal impairment, and what are the contraindications, precautions, and alternative monotherapy options for elderly patients?
What are the causes of left anterior hemiblock?
What is the appropriate first‑line treatment for blepharitis in an adult contact‑lens wearer?
For an adult with type 1 diabetes whose fasting blood glucose is 262 mg/dL and 351 mg/dL, currently on 20 U insulin glargine (Lantus) overnight and a carbohydrate‑to‑insulin ratio of 1 U per 10 g, how should the basal insulin dose be increased and what correction bolus should be added for each glucose reading?
How is escitalopram pronounced?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.